Jun 10, 2010 09:00 StemCells, Inc.'s GS2-M(TM) Media Formulation Shown to Enhance Pluripotency of Human Stem Cells
StemCells, Inc. (Nasdaq:STEM) announced today that newly published independent research demonstrates that its GS2-M(tm) cell culture media formulation enhances the pluripotency of human embryonic stem (ES) and induced pluripotent stem (iPS) cells. The Company's GS2-M medium has already been shown to enable the derivation and long-term maintenance of mouse iPS cells. With this new application of GS2-M, researchers may now be able to significantly advance human pluripotent stem cell research. continued...